Companies / Hungary
KV To Market Gedeon's Generics In The US
February 2006 | Company Finance AlertHungarian drugmaker Gedeon Richter has recruited US-based KV Pharmaceutical to commercialise a selection of its developmental generic products in the US.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
